Methods of synthesizing cannabielsoin and analogs thereof
Disclosed are methods for synthesizing cannabielsoin (CBE) and or analogs thereof. In particular, the present disclosure provides methods for synthesizing CBE or analogs thereof comprising steps of providing a cannabinoid composition that comprises cannabidiol (CBD) or analogs thereof; combining the cannabinoid composition with an agent comprising a ketone functional group; and contacting the cannabinoid composition with an oxidizing agent or exposing the cannabinoid composition to electromagnetic radiation.
1. A method for synthesizing cannabielsoin (CBE) or an analog thereof, the method comprising mixing CBD or an analog thereof, an agent comprising a ketone functional group, and an oxidizing agent.
2. The method of claim 1 , wherein the agent comprising a ketone functional group is acetone, oxaloacetate, diacetyl, acetyl acetone, ethyl methyl ketone, isopropyl methyl ketone, benzophenone, acetophenone, cyclopropanone, cyclobutanone, cyclohexanone, isophorone, or methyl vinyl ketone.
3. The method of claim 2 , wherein the agent comprising a ketone functional group is acetone.
4. The method of claim 1 , wherein the oxidizing agent is selected from the group consisting of persulfates, peroxides, peracids, hypochlorites, and halogens.
5. The method of claim 1 , wherein the oxidizing agent is potassium monopersulfate, tetrabutylammonium hydrogen monopersulfate, hydrogen peroxide, tertbutyl hydrogen peroxide (TBHP), cumene hydroperoxide (CHP), meta-chloroperbenzoic acid (mCPBA), or sodium hypochlorite.
6. The method of claim 5 , wherein the oxidizing agent is potassium monopersulfate.
7. A method for synthesizing cannabielsoin (CBE) or an analog thereof, the method comprising steps of:
mixing cannabidiol (CBD) or an analog thereof with an agent comprising a ketone functional group; and
exposing the mixture to electromagnetic radiation.
8. The method of claim 7 , wherein the electromagnetic radiation is ultraviolet (UV) radiation.
9. The method of claim 8 , wherein the UV radiation has a wavelength that is between about 100 nm and about 400 nm.
10. The method of claim 8 , wherein the UV radiation has a wavelength that is between about 280 nm and about 400 nm.
11. The method of claim 7 , wherein the agent comprising a ketone functional group is acetone, oxaloacetate, diacetyl, acetyl acetone, ethyl methyl ketone, isopropyl methyl ketone, benzophenone, acetophenone, cyclopropanone, cyclobutanone, cyclohexanone, isophorone, or methyl vinyl ketone.
12. The method of claim 11 , wherein the agent comprising a ketone functional group is acetone.
13. The method of claim 1 , wherein the CBD or an analog thereof has the structure of:
wherein R 3 is hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, (OCH 2 CH 2 ) 0-6 O(C 1 -C 8 alkyl), (C 0 -C 4 alkyl)-NR 2a R 2b , (C 0 -C 4 alkyl)-aryl, (C 0 -C 4 alkyl)-heteroaryl, (C 0 -C 4 alkyl)-cycloalkyl, or (C 0 -C 4 alkyl)-heterocycloalkyl, wherein R 2a R 2b are each independently hydrogen or C 1 -C 6 alkyl.
14. The method of claim 13 , wherein R 3 is C 1 -C 12 alkyl.
15. The method of claim 13 , wherein R 3 is C 5 H 11 .
16. The method of claim 13 , wherein R 3 is methyl, ethyl, propyl, butyl, heptyl, 1,1-dimethylheptyl, phenylethyl, or phenylvinyl.
17. The method of claim 7 , wherein the CBD or an analog thereof has the structure of:
wherein R 3 is hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, (OCH 2 CH 2 ) 0-6 O(C 1 -C 8 alkyl), (C 0 -C 4 alkyl)-NR 2a R 2b , (C 0 -C 4 alkyl)-aryl, (C 0 -C 4 alkyl)-heteroaryl, (C 0 -C 4 alkyl)-cycloalkyl, or (C 0 -C 4 alkyl)-heterocycloalkyl, wherein R 2a R 2b are each independently hydrogen or C 1 -C 6 alkyl.
18. The method of claim 17 , wherein R 3 is C 1 -C 12 alkyl.
19. The method of claim 17 , wherein R 3 is C 5 H 11 .
20. The method of claim 17 , wherein R 3 is methyl, ethyl, propyl, butyl, heptyl, 1,1-dimethylheptyl, phenylethyl, or phenylvinyl.